-Jin Dai Researcher Activity Profile

Research Author Detailed Information 

Jin Dai Publication Rate By Year

Jin Dai has published 7 paper(s) in 2007, for a total of 7 research publications in total.

Jin J Dai Author Information

LAST NAME: dai

FIRST NAME: jin

INITIALS: J

AFFILIATION:

Papers

Jin Dai's Publication Record

1. Formulation and in-vitro and in-vivo evaluation of a mucoadhesive gel containing freeze dried black raspberries: implications for oral cancer chemoprevention. Year Published: 2007
Department of Oral Maxillofacial Surgery & Pathology, College of Dentistry, The Ohio State University, Columbus, OH 43210-1241, USA. mallery.1@osu.edu
2. Characterization of blackberry extract and its antiproliferative and anti-inflammatory properties. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.
3. AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus. Year Published: 2007
Psychiatry Department, Vanderbilt University School of Medicine, Nashville, TN USA. Zhu.Li@Vanderbilt.Edu
4. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: Potentiation of risperidone-, but not haloperidol-, induced dopamine efflux. Year Published: 2007
Psychology Department, Northern Michigan University, 1401 Presque Isle Ave., Marquette, MI 49855, USA.
5. Lack of association of single nucleotide polymorphism in LRCH1 with knee osteoarthritis susceptibility. Year Published: 2007
The Center of Diagnosis and Treatment for Joint Disease, Drum Tower Hospital Affiliated to Medical School of Nanjing University, Nanjing, 210008, Jiangsu, China, qingj@nju.edu.cn.
6. AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus. Year Published: 2007
Psychiatry Department, Vanderbilt University School of Medicine, Nashville, TN USA. Zhu.Li@Vanderbilt.Edu
7. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux. Year Published: 2007
Psychology Department, Northern Michigan University, Marquette, MI 49855, USA. aprus@nmu.edu